Plasma Treatment Improved Surface Properties and Enhanced Cell Adhesion on Poly-ε-Caprolactone for Heart Valve Tissue Engineering Applications
The Thoracic and Cardiovascular Surgeon · 2026-01 · 74 (S 02) · S71-S98
DOI: 10.1055/s-0046-1817372 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, online erschienen am 17.02.2026. Verfasst von M. Saeid Nia und 12 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
Tissue engineering (TE), a multidisciplinary alternative solution, provides an assured substitution of damaged tissues by combining engineering with biomedicine. A tissue-engineered heart valve is a fully functional tissue product facilitated through the cultivation of autologous cells on appropriate scaffolds. Scaffold’s surface charge and wettability are the main factors that significantly affect cell adhesion, which is known to be favorable on hydrophilic surfaces. Moreover, biocompatible scaffolds that induce a minimal immunogenic response are also essential for successful tissue engineering. However, commonly used biocompatible polymers in industry with preferable bulk properties lack desirable surface properties. For example, biomedical polymers, such as poly-ε-caprolactone (PCL) or polylactic acid (PLA), which are widely used as scaffolds in TE, are known for their satisfying structural and mechanical properties, but due to their surface characteristics, cell attachment and consequently cell growth on these polymers are limited.
Methods
In this study, we investigated the possible effect of H2-N2 plasma treatment on PCL surface wettability to see the feasibility of improvement in cell adhesion and proliferation.
Results
Our results showed an increase in the hydrophilicity of the 300 nm-PCL specimens after plasma treatment, which was followed by a significant enhancement in cell attachment without altering PCL mechanical properties.
Conclusion
Plasma surface modification is an assuring approach that can be used to improve PCL cell adhesion and, consequently, cell growth without altering its bulk properties and fiber morphology. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Nia, M. S., Seiler, J. A., Schütrumpf, J., Jesaitis, L., Schneider, V., Kersten, H., Puehler, T., Pommert, N. S., Attmann, T., Sellers, S., Meier, D., Warnecke, G., & Lutter, G. (2026). Plasma Treatment Improved Surface Properties and Enhanced Cell Adhesion on Poly-ε-Caprolactone for Heart Valve Tissue Engineering Applications. The Thoracic and Cardiovascular Surgeon, 74(S 02), S71-S98. https://doi.org/10.1055/s-0046-1817372
Vancouver
Nia MS, Seiler JA, Schütrumpf J, Jesaitis L, Schneider V, Kersten H, et al. Plasma Treatment Improved Surface Properties and Enhanced Cell Adhesion on Poly-ε-Caprolactone for Heart Valve Tissue Engineering Applications. The Thoracic and Cardiovascular Surgeon. 2026;74(S 02):S71-S98. doi:10.1055/s-0046-1817372
BibTeX
@article{Nia2026,
author = {Nia, M. Saeid and Seiler, J. A. and Schütrumpf, J. and Jesaitis, L. and Schneider, V. and Kersten, H. and Puehler, T. and Pommert, N. S. and Attmann, T. and Sellers, S. and Meier, D. and Warnecke, G. and Lutter, G.},
title = {Plasma Treatment Improved Surface Properties and Enhanced Cell Adhesion on Poly-ε-Caprolactone for Heart Valve Tissue Engineering Applications},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 02},
pages = {S71--S98},
doi = {10.1055/s-0046-1817372}
}
EUVIMED